Immunologic effects plasmapheresis pulse cyclophosphamide systemic lupus erythematosus Extensive immunologic evaluation patient severe systemic lupus erythematosus SLE cycles plasmapheresis pulsed cyclophosphamide therapy Clinical remission normalization levels autoantibodies immune complexes complement proteins interleukin receptor High spontaneous peripheral blood lymphocyte proliferation plasmapheresis cyclophosphamide cells low year recovery serum IgG level cells chiefly naive cell subset emergence cell mature cytotoxic/suppressive cells autoreactive cell populations cyclophosphamide plasmapheresis immune system patient association immunological changes clinical recovery warrants investigation new therapeutic approach SLE 